Friday telehealth news roundup
Seeing what is barely there: A team at Imperial College (London) has developed a low-cost, fast ‘ultra-sensitive sensor’ of the p24 biomarker for prostate cancer (PSA) and HIV. Nanoparticles in serum from blood samples, put in a disposable container, indicate… Read moreFriday telehealth news roundup